Carteolol (CAS 51781-06-7) Suppliers and Product Information

Carteolol is a non-selective beta-adrenergic receptor antagonist used in the treatment of glaucoma and ocular hypertension. It reduces intraocular pressure by decreasing aqueous humor production. Carteolol also exhibits antihypertensive, antianginal, and antiarrhythmic properties.

Chemical Properties: - Boiling Point: 434.3°C (estimated) - Density: 1.0574 g/cm3 (estimated) - pKa: 13.84

Carteolol is almost completely absorbed when administered orally and exhibits about 30% binding to plasma proteins. Unlike many beta-blockers, it is not extensively metabolized.

Frequently Asked Questions

Q: What are the main uses of Carteolol?

A: Carteolol is primarily used as an antiglaucoma agent to reduce intraocular pressure. It also has applications as an antihypertensive, antianginal, and antiarrhythmic drug.

Q: How does Carteolol work?

A: Carteolol acts as a non-selective beta-adrenergic receptor antagonist. In the eye, it reduces aqueous humor production by decreasing cyclic AMP synthesis in the ciliary body, thereby lowering intraocular pressure.

Q: Are there any known side effects or allergic reactions associated with Carteolol?

A: Carteolol has been implicated in allergic contact dermatitis when used in eye drops. However, it may be safely used in some patients with hypersensitivity to other topical beta-blocker agents.